无症状筛查或息肉切除后监测结肠镜检查中常规回肠末端插管的诊断率与实用性:系统综述与荟萃分析
汇总总体诊断率为1.74%(95%CI 1.18-2.57),临床显著病变诊断率仅0.28%(95%CI 0.07-1.05),克罗恩病(CD)检出率0.1%(95%CI 0.02-0.44)。结论不支持在该人群常规行TII。
要点
- 无症状筛查/监测结肠镜中常规TII总体诊断率1.74%,多为非特异性异常。
- 临床显著病变诊断率仅0.28%,CD检出率0.1%(约每1000次回肠镜检查1例)。
- 研究结果不支持在该无症状人群常规行回肠末端插管。
核心结论
- 无症状筛查或监测结肠镜检查中常规TII对临床显著病变(包括CD)的诊断率极低,不支持常规实施。
主要发现
- TII对任何回肠病变的汇总总体诊断率为1.74%(95%CI 1.18-2.57),多数异常为非特异性且无需临床处理。
- 临床显著病理的诊断率为0.28%(95%CI 0.07-1.05)。
- CD检出率为0.1%(95%CI 0.02-0.44),相当于结直肠癌筛查结肠镜检查中每1000次回肠镜检查发现1例。
关键数值与推荐
- 主要结局为TII总体诊断率1.74%(95%CI 1.18-2.57)。
- 次要结局包括临床显著病变诊断率0.28%(95%CI 0.07-1.05)和CD诊断率0.1%(95%CI 0.02-0.44)。
- TII对操作时长的影响为次要结局,原文摘要未报告具体数值。
临床怎么用
- 在无症状结直肠癌筛查或息肉切除后监测结肠镜检查中,不推荐常规行回肠末端插管。
- 应结合临床情况个体化决定是否行TII,而非作为该人群的常规质量指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: The role of routine terminal ileal intubation (TII) in asymptomatic patients undergoing colonoscopy for colorectal cancer (CRC) screening or postpolypectomy surveillance is debated. Although considered a quality indicator in some settings, its clinical utility in this population remains unclear. This systematic review and meta-analysis aimed to evaluate the diagnostic yield, clinical utility, and procedural impact of routine TII in patients undergoing CRC screening or postpolypectomy surveillance. METHODS: We conducted a systematic search of PubMed and Embase up to September 2025, according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. We included studies reporting TII diagnostic yield in asymptomatic adults undergoing CRC screening or postpolypectomy surveillance colonoscopy. Data were synthesized using random-effects models. The primary outcome was the overall diagnostic yield of TII. Secondary outcomes included the diagnostic yield for clinically significant findings, Crohn's disease (CD), and the impact of TII on procedure duration. RESULTS: Eleven studies involving 25,659 patients were included, of whom 13,672 underwent TII. The pooled overall diagnostic yield for any ileal finding was 1.74% (95% CI, 1.18-2.57), with most abnormalities being nonspecific and not requiring clinical action. The diagnostic yield for clinically significant pathology was substantially lower at 0.28% (95% CI, 0.07-1.05), whereas the yield for detecting CD was only 0.1% (95% CI, 0.02-0.44), corresponding to 1 case per 1000 ileoscopies during colonoscopy for CRC screening. CONCLUSIONS: Routine TII in asymptomatic patients undergoing screening or surveillance colonoscopy provides a negligible diagnostic yield for clinically significant pathology, including CD. Our findings do not support performing routine TII during colonoscopy in this patient population.
引用
- Scalvini D, Maimaris S, Cappellini A, et al. Diagnostic yield and usefulness of terminal ileal intubation in asymptomatic patients undergoing colonoscopy for colorectal cancer screening or postpolypectomy surveillance: a systematic review and meta-analysis. Gastrointest Endosc. 2026. PMID: 41833622. doi:10.1016/j.gie.2026.02.056
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。